Monopar Therapeutics (MNPR) Return on Capital Employed (QoQ) (2018 - 2025)

Monopar Therapeutics (MNPR) Return on Capital Employed (QoQ) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Monopar Therapeutics 800.03 Mn 738.20 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 600.00
Sep 30, 2023 -1,285.00
Jun 30, 2023 -849.00
Mar 31, 2023 -1,158.00
Dec 31, 2022 -2,303.00
Sep 30, 2022 -728.00
Jun 30, 2022 -1,491.00
Mar 31, 2022 -741.00
Mar 31, 2021 453.00
Dec 31, 2020 -304.00
Sep 30, 2020 62.00
Jun 30, 2020 -540.00
Mar 31, 2020 1,880.00
Dec 31, 2019 3,185.00
Sep 30, 2019 -1,125.00
Jun 30, 2019 -1,279.00
Mar 31, 2019 -1,479.00
Dec 31, 2018 -605.00
Sep 30, 2018 16,516.00
Jun 30, 2018 -1,779.00